Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study

Abstract

PURPOSE: To describe the frequency, content, dynamics, and patterns of cost conversations in academic medical oncology across tumor types. PATIENTS AND METHODS: We reviewed 529 audio recordings between May 3, 2012, to September 23, 2014, from a prospective three-site communication study in which patients at any stage of management for any solid tumor malignancy were seen in routine oncology appointments. Recordings were deidentified, transcribed, and flagged for any mention of cost. We coded encounters and used qualitative thematic analysis. RESULTS: Financial issues were discussed in 151 (28%) of 529 recordings. Conversations lasted shorter than 2 minutes on average. Patients/caregivers raised a majority of discussions (106 of 151), and 40% of cost concerns raised by patients/caregivers were not verbally acknowledged by clinicians. Social service referrals were made only six times. Themes from content analysis were related to insurance eligibility/process, work insecurity, cost of drugs, cost used as tool to influence medical decision making, health care–specific costs, and basic needs. Financial concerns influenced oncology work processes via test or medication coverage denials, creating paperwork for clinicians, potentially influencing patient involvement in trials, and leading to medication self-rationing or similar behaviors. Typically, financial concerns were associated with negative emotions. CONCLUSION: Financial issues were raised in approximately one in four academic oncology visits. These brief conversations were usually initiated by patients/caregivers, went frequently unaddressed by clinicians, and seemed to influence medical decision making and work processes and contribute to distress. Themes identified shed light on the kinds of gaps that must be addressed to help patients with cancer cope with the rising cost of care.

Taboo Topics in Adolescent and Young Adult Oncology: Strategies for Managing Challenging but Important Conversations Central to Adolescent and Young Adult Cancer Survivorship

“…79 Common cost concerns raised by patients with cancer across studies include clinician's lack of time to attend to insurance eligibility/coverage, worries that costs may affect a clinician's decisionmaking and the patient-clinician relationship, and the cost of specific tests and visits. [80][81][82] Many of these are concerns common to AYA patients with cancer, who can feel lost in an unfamiliar health care system, and are complicated by AYA patients' insurance coverage.…”

“…82 Few patients with cancer report having cost conversations with their medical clinicians, and for those who do, conversations are often brief and occur at a single point in time. 80,98 Although there is limited evidence, patients who discuss costs with their oncology clinicians do report lower out-of-pocket costs. 99 Specifically, clinicians can help by starting a cost conversation with patients to understand if financial concerns are affecting patient decision-making around care.…”

The high cost of prescription drugs: causes and solutions

“…Prices of common prescription drugs can vary markedly in the United States, and physicians can help patients by directing them to the pharmacy with the lowest prices using resources such as goodrx.com 22 . Physicians must become more educated on drug prices, and discuss affordability with patients 23 .…”

The High Cost of Insulin in the United States: An Urgent Call to Action

“…Even when patients raised the issue, they were met with inadequate responses or silence. 33 An investigation by Consumer Reports 34 found that for common drugs, the price difference across pharmacies can be astonishing. For example, for clopidogrel, the cost was $10 per month at HealthWarehouse vs $141 at CVS.…”